Abnormalities, Drug-Induced
"Abnormalities, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Descriptor ID |
D000014
|
| MeSH Number(s) |
C16.131.042
|
| Concept/Terms |
Abnormalities, Drug-Induced- Abnormalities, Drug-Induced
- Abnormalities, Drug Induced
- Drug-Induced Abnormalities
- Abnormality, Drug-Induced
- Drug Induced Abnormalities
- Drug-Induced Abnormality
|
Below are MeSH descriptors whose meaning is more general than "Abnormalities, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Abnormalities, Drug-Induced".
This graph shows the total number of publications written about "Abnormalities, Drug-Induced" by people in this website by year, and whether "Abnormalities, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abnormalities, Drug-Induced" by people in Profiles.
-
Chang L, Oishi K, Skranes J, Buchthal S, Cunningham E, Yamakawa R, Hayama S, Jiang CS, Alicata D, Hernandez A, Cloak C, Wright T, Ernst T. Sex-Specific Alterations of White Matter Developmental Trajectories in Infants With Prenatal Exposure to Methamphetamine and Tobacco. JAMA Psychiatry. 2016 Dec 01; 73(12):1217-1227.
-
Terplan M, Wright T. The effects of cocaine and amphetamine use during pregnancy on the newborn: myth versus reality. J Addict Dis. 2011 Jan; 30(1):1-5.
-
Waller DK, Gallaway MS, Taylor LG, Ramadhani TA, Canfield MA, Scheuerle A, Hern?ndez-Diaz S, Louik C, Correa A. Use of oral contraceptives in pregnancy and major structural birth defects in offspring. Epidemiology. 2010 Mar; 21(2):232-9.
-
Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti PA, Mitchell AA, Olney RS, Correa A. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension. 2009 Jul; 54(1):63-70.
-
Cloak CC, Ernst T, Fujii L, Hedemark B, Chang L. Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology. 2009 Jun 16; 72(24):2068-75.
-
Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol. 2009 Feb; 85(2):137-50.
-
Ishaque AB, Tchounwou PB, Wilson BA, Washington T. Developmental arrest in Japanese medaka (Oryzias latipes) embryos exposed to sublethal concentrations of atrazine and arsenic trioxide. J Environ Biol. 2004 Jan; 25(1):1-6.
-
Paulsen DF. Retinoic acid in limb-bud outgrowth: review and hypothesis. Anat Embryol (Berl). 1994 Nov; 190(5):399-415.
-
Lozanoff S, Diewert VM. Measuring histological form change with finite element methods: an application using diazo-oxo-norleucine (DON)-treated rats. Am J Anat. 1986 Oct; 177(2):187-201.
-
Willhite CC, Balogh-Nair V. Teratogenic profile of retinylidene methyl nitrone and retinol in Swiss-Webster mice. Teratog Carcinog Mutagen. 1985; 5(5):355-63.